Craniofacial tissue engineering with human embryonic and adult derived stem cells
Craniofacial tissue engineering with human embryonic and adult derived stem cells
批准号:
7596274
负责人:
ROBERT Samuel LANGER
金额:
$36.98万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2010-03-31
关键词:
3-DimensionalAdultAnimal ModelBiochemical MarkersBone RegenerationCalciumCartilageCell ProliferationCellsCephalicChondrocytesCollagen Type IIDefectDentalEmbryoEnvironmentExtracellular MatrixFactor AnalysisGenesGlycosaminoglycansGrowth FactorGrowth Factor GeneHumanImplantIn VitroMeasuresMechanicsMedicineModelingNude RatsOsteoblastsOsteocalcinPhenotypePolyestersPolymersProductionPropertyRattusRecording of previous eventsScreening procedureStaining methodStainsStem cellsSurfaceTechniquesTechnologyTestingTissue EngineeringTissuesUndifferentiatedWorkbiomaterial developmentblastomere structurebonecell typeclinically relevantcraniofacialcraniofacial complexembryonic stem cellhigh throughput screeninghuman embryonic stem cellhuman stem cellsin vivomonomernanolitre scalenovelrapid techniqueregenerativeresponsescaffoldsubcutaneoussuccesstissue regenerationtissue support frame
中文摘要
描述(由申请人提供):我们建议使用我们在生物材料发展方面建立和记录良好的历史,作为组织替代支架,作为颅面组织再生干细胞方法的平台。这项工作的主要假设包括:1)胚胎来源的人类干细胞可以分化为颅面组织生成细胞,如成骨细胞和软骨细胞,2)高通量技术可用于筛选大量潜在用于组织工程支架的培养基和聚合物候选物,3)干细胞与三维聚合物支架的适当组合可用于复杂颅面组织的生产。为了验证这些假设,我们提出以下建议:目的1:研究人类胚胎干细胞向颅面组织前体的体外分化。我们之前研究人类胚胎干细胞在体外分化为各种细胞类型和组织的工作将继续评估分化为颅面组织形成所需的细胞类型所需的条件。
英文摘要
DESCRIPTION (provided by applicant): We propose to use our established and well documented history in the development of biomaterials as scaffolding for tissue replacement as a platform for stem cell approaches in craniofacial tissue regeneration. The governing hypotheses of this work include: i) that human stem cells of embryonic origin can be differentiated into craniofacial tissue producing cells such as osteoblasts and chondrocytes, ii) that highthroughput techniques can be used for the screening of large numbers of media and polymer candidates for potential use with tissue engineering scaffolds, and iii) that the appropriate combination of stem cells with 3-dimensional polymer scaffolds can be used for the production of complex craniofacial tissues. To test these hypotheses, we propose the following: Aim 1: Examine the in vitro differentiation of human embryonic stem cells into precursors of craniofacial tissues. Our previous work investigating the in vitro differentiation of human embryonic stem cells into various cell types and tissues will be continued to assess conditions necessary for differentiation into cell types necessary for craniofacial tissue formation.
Aim 2: Investigate the interaction of human stem cells with polymer surfaces using high-throughput screening technology. Recently, we have developed techniques for the rapid screening of cell/polymer interactions using nanoliter-scale microarrays of various monomers and polymers. Success will be assessed through cell proliferation and the presence of tissue specific markers for craniofacial tissues. Aim 3: Assess in vitro tissue production by differentiated and undifferentiated human embryonic stem cell seeded polymeric scaffolds incorporating various genes and growth factors. Polymeric materials that support the differentiation of human stem cells into craniofacial tissues will be fabricated into 3-dimensional scaffolds incorporating various genes and growth factors and analyzed by histological staining of various markers. Aim 4: Optimal candidates from the previous aims will be seeded with differentiated and undifferentiated cells and implanted either subcutaneously or in a critical sized defect model in rats. The subcutaneous model in athymic rats will be used to assess tissue production by stem cell seeded scaffolds in an in vivo environment, including scaffolds with cells differentiated into multiple phenotypes. The cranial defect model in athymic rats is a clinically relevant model that is commonly used as a measure of bone regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MIT-Harvard Center of Cancer Nanotechnology Excellence
-
批准号:8722461
-
项目类别:
-
资助金额:$221.26万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Administrative Core
-
批准号:7983683
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
-
批准号:7983673
-
项目类别:
-
资助金额:$90.15万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Education/Training and Outreach Activities
-
批准号:7983697
-
项目类别:
-
资助金额:$4.5万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
MIT-Harvard Center of Cancer Nanotechnology Excellence
-
批准号:8136182
-
项目类别:
-
资助金额:$229.0万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
MIT-Harvard Center of Cancer Nanotechnology Excellence
-
批准号:8322534
-
项目类别:
-
资助金额:$228.69万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
MIT-Harvard Center of Cancer Nanotechnology Excellence
-
批准号:7976489
-
项目类别:
-
资助金额:$229.54万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Developmental Activities
-
批准号:7983702
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
MIT-Harvard Center of Cancer Nanotechnology Excellence
-
批准号:8547003
-
项目类别:
-
资助金额:$221.35万
-
财政年份:2010
-
负责人:ROBERT Samuel LANGER
-
依托单位:
The MIT-Harvard Center of Cancer Nanotechnology Excelle*
-
批准号:7928452
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:ROBERT Samuel LANGER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7738130
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2008
-
负责人:ROBERT Samuel LANGER
-
依托单位:
PILOT STUDIES
-
批准号:7738132
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2008
-
负责人:ROBERT Samuel LANGER
-
依托单位:
TARGETED POLYMERIC NANOPARTICLES FOR CANCER THERAPY
-
批准号:7738122
-
项目类别:
-
资助金额:$41.57万
-
财政年份:2008
-
负责人:ROBERT Samuel LANGER
-
依托单位:
EDUCATION, TRAINING, AND OUTREACH CORE
-
批准号:7738131
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2008
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Craniofacial tissue engineering with human embryonic an*
-
批准号:7035847
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2005
-
负责人:ROBERT Samuel LANGER
-
依托单位:
High-Throughput Craniofacial tissue engineering
-
批准号:8034341
-
项目类别:
-
资助金额:$38.7万
-
财政年份:2005
-
负责人:ROBERT Samuel LANGER
-
依托单位:
The MIT-Harvard Center of Cancer Nanotechnology Excelle*
-
批准号:7496578
-
项目类别:
-
资助金额:$431.36万
-
财政年份:2005
-
负责人:ROBERT Samuel LANGER
-
依托单位:
High-Throughput Craniofacial tissue engineering
-
批准号:8403394
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2005
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Craniofacial tissue engineering with human & adult ESCs
-
批准号:6890595
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2005
-
负责人:ROBERT Samuel LANGER
-
依托单位:
Craniofacial tissue engineering with human embryonic and adult derived stem cells
-
批准号:7385976
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:ROBERT Samuel LANGER
-
依托单位:
海外基金